[1]
|
Bray, F., Ferlay, J., Soerjomataram, I., et al. (2018) Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 68, 394-424.
https://doi.org/10.3322/caac.21492
|
[2]
|
Blot, W.J. and Tarone, R.E. (2017) Esophageal Cancer. In: Thun, M.J., Linet, M.S., Cerhan, J.R., Haiman, C.A. and Schottenfeld, D., Eds., Cancer Epidemiology and Prevention, 4th Edition, Oxford University Press, New York, 579-592.
|
[3]
|
Castro, C., Bosetti, C., Malvezzi, M., et al. (2014) Patterns and Trends in Esophageal Cancer Mortality and Incidence in Europe (1980-2011) and Predictions to 2015. Annals of Oncology, 25, 283-290.
https://doi.org/10.1093/annonc/mdt486
|
[4]
|
Smyth, E.C., Lagergren, J., Fitzgerald, R.C., et al. (2017) Oesophageal Cancer. Nature Reviews Disease Primers, 3, Article No. 17048. https://doi.org/10.1038/nrdp.2017.48
|
[5]
|
Lagergren, J., Smyth, E., Cunningham, D. and Lagergren, P. (2017) Oesophageal Cancer. The Lancet, 390, 2383-2396.
https://doi.org/10.1016/S0140-6736(17)31462-9
|
[6]
|
Arnold, M., Soerjomataaram, I., Ferlay, J., et al. (2015) Global Incidence of Oesophageal Cancer by Histological Subtype in 2012. Gut, 64, 381-387.
|
[7]
|
Njei, B., McCarty, T.R. and Birk, J.W. (2016) Trends in Esophageal Cancer Survival in United States Adults from 1973 to 2009: A SEER Database Analysis. Journal of Gastroenterology and Hepatology, 31, 1141-1146.
https://doi.org/10.1111/jgh.13289
|
[8]
|
Njei, B., McCarty, T.R. and Birk, J.W. (2016) Trends in Esophageal Cancer Survival in United States Adults from 1973 to 2009: A SEER Database Analysis. Journal of Gastroenterology and Hepatology, 31, 1141-1146.
https://doi.org/10.1111/jgh.13289
|
[9]
|
Alsop, B.R. and Sharma, P. (2016) Esophageal Cancer. Gastroenterology Clinics of North America, 45, 399-412.
https://doi.org/10.1016/j.gtc.2016.04.001
|
[10]
|
Souza, R.F., Krishnan, K. and Spechler, S.J. (2008) Acid, Bile, and CDX: The ABCs of Making Barrett’s Metaplasia. American Journal of Physiology-Gastrointestinal and Liver Physiology, 295, G211-G218.
https://doi.org/10.1152/ajpgi.90250.2008
|
[11]
|
Islami, F. and Kamangar, F. (2008) Helicobacter pylori and Esophageal Cancer Risk: A Meta-Analysis. Cancer Prevention Research, 1, 329-338. https://doi.org/10.1158/1940-6207.CAPR-08-0109
|
[12]
|
Siewert, J.R. and Ott, K. (2007) Are Squamous and Adenocarcinomas of the Esophagus the Same Disease? Seminars in Radiation Oncology, 17, 38-44. https://doi.org/10.1016/j.semradonc.2006.09.007
|
[13]
|
Edgren, G., Adami, H.O., Weiderpass, E. and Nyren, O. (2013) A Global Assessment of the Oesophageal Adenocarcinoma Epidemic. Gut, 62, 1406-1414.
|
[14]
|
Kitadani, J., Nakamura, M., Ojima, T., Katsuda, M., Hayata, K. and Yamaue, H. (2020) A Phase II Study of Neoadjuvant Chemotherapy with DCS for Resectable Advanced Esophageal Cancer. Journal of Clinical Oncology, 38, 366.
https://doi.org/10.1200/JCO.2020.38.4_suppl.366
|
[15]
|
Shapiro, J., van Lanschot, J.J., Hulshof, M.C., et al. (2015) Neoadjuvant Chemoradiotherapy plus Surgery versus Surgery alone for Oesophageal or Junctional Cancer (CROSS): Long-Term Results of a Randomised Controlled Trial. The Lancet Oncology, 16, 1090-1098. https://doi.org/10.1016/S1470-2045(15)00040-6
|
[16]
|
van Hagen, P., Hulshof, M.C., van Lanschot, J.J., et al. (2012) Preoperative Chemoradiotherapy Foresophageal or Junctional Cancer. The New England Journal of Medicine, 366, 2074-2084. https://doi.org/10.1056/NEJMoa1112088
|
[17]
|
Bedenne, L., Michel, P., Bouché, O., et al. (2007) Chemoradiation Followed by Surgery Compared with Chemoradiation Alone in Squamous Cancer of the Esophagus: FFCD 9102. Journal of Clinical Oncology, 25, 1160-1168.
https://doi.org/10.1200/JCO.2005.04.7118
|
[18]
|
Stahl, M., Stuschke, M., Lehmann, N., et al. (2005) Chemoradiation with and without Surgery in Patients with Locally Advanced Squamous Cell Carcinoma of the Esophagus. Journal of Clinical Oncology, 23, 2310-2317.
https://doi.org/10.1200/JCO.2005.00.034
|
[19]
|
Homs, M.Y., Steyerberg, E.W., Eijkenboom, W.M., et al. (2004) Single-Dose Brachytherapy versus Metal Stent Placement for the Palliation of Dysphagia from Oesophageal Cancer: Multicentre Randomised Trial. The Lancet, 364, 1497-1504. https://doi.org/10.1016/S0140-6736(04)17272-3
|
[20]
|
Huang, F.-L. and Yu, S.-J. (2018) Esophageal Cancer: Risk Factors, Genetic Association, and Treatment. Asian Journal of Surgery, 41, 210-215. https://doi.org/10.1016/j.asjsur.2016.10.005
|
[21]
|
Pennathur, A., Gibson, M.K., Jobe, B.A., et al. (2013) Oesophageal Carcinoma. The Lancet, 381, 400-412.
https://doi.org/10.1016/S0140-6736(12)60643-6
|
[22]
|
Lerut, T., De Leyn, P., Coosemans, W., et al. (1992) Surgical Strategies in Esophageal Carcinoma with Emphasis on Radical Lymphadenectomy. Annals of Surgery, 216, 583-590. https://doi.org/10.1097/00000658-199211000-00010
|
[23]
|
Lund, O., Hasenkam, J.M., Aagaard, M.T., et al. (1989) Time-Related Changes in Characteristics of Prognostic Significance in Carcinomas of the Oesophagus and Cardia. British Journal of Surgery, 76, 1301-1307.
https://doi.org/10.1002/bjs.1800761227
|
[24]
|
Siewert, J.R., Stein, H.J., Feith, M., et al. (2001) Histologic Tumor Type Is an Independent Prognostic Parameter in Esophageal Cancer: Lessons from More than 1000 Consecutive Resections at a Single Center in the Western World. Annals of Surgery, 234, 360-367. https://doi.org/10.1097/00000658-200109000-00010
|
[25]
|
Holscher, A.H., Bollschweiler, E., Schneider, P.M., et al. (1995) Prognosis of Early Esophageal Cancer. Comparison between Adeno- and Squamous Cell Carcinoma. Cancer, 76, 178-186.
https://doi.org/10.1002/1097-0142(19950715)76:2<178::AID-CNCR2820760204>3.0.CO;2-D
|